James F Strauss (James Strauss)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Pluripotent Stem Cells

Escherichia Coli

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Jason John Luke, Sarina A Piha-Paul, Theresa M Medina, Claire F Verschraegen, Mary Varterasian, Aoife M Brennan, Richard J Riese, Anna Sokolovska, James F Strauss, David L Hava, Filip Janku
Phase I study of SYNB1891, an engineered E coli Nissle strain expressing STING agonist, with and without atezolizumab in advanced malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Jason John Luke, Sarina A Piha-Paul, Theresa M Medina, Claire F Verschraegen, Mary Varterasian, Aoife M Brennan, Richard J Riese, Anna Sokolovska, James F Strauss, David L Hava, Filip Janku
Phase I Study of SYNB1891, an Engineered E. coli Nissle Strain Expressing STING Agonist, with and without Atezolizumab in Advanced Malignancies. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Isabel Kurth, Norihiro Yamaguchi, Celia Andreu-Agullo, Helen S Tian, Subhasree Sridhar, Shugaku Takeda, Foster C Gonsalves, Jia Min Loo, Afsar Barlas, Katia Manova, Robert W Busby, Johanna C Bendell, James F Strauss, Marwan G Fakih, Autumn J McRee, Andrew E Hendifar, Lee S Rosen, Andrea Cercek, Robert Wasserman, Michael Szarek, Scott L Spector, Syed Raza, Masoud F Tavazoie
Therapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression and modulates human creatine levels. Science advances 7 (41) (2021)